Patents by Inventor Emil Chuang

Emil Chuang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF GASTROPARESIS WITH TRIAZASPIRO[4.5]DECANONE
    Publication number: 20230346757
    Abstract: Provided herein is a method of treating or alleviating one or more symptoms of a disorder, disease, or condition mediated by a dopamine D2 or D3 receptor with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof. Also provided herein is a method of increasing the serum prolactin level with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 5, 2023
    Publication date: November 2, 2023
    Inventor: Emil Chuang
  • TREATMENT OF GASTROPARESIS WITH TRIAZASPIRO[4.5]DECANONE
    Publication number: 20230114615
    Abstract: Provided herein is a method of treating or alleviating one or more symptoms of a disorder, disease, or condition mediated by a dopamine D2 or D3 receptor with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof. Also provided herein is a method of increasing the serum prolactin level with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 8, 2022
    Publication date: April 13, 2023
    Inventor: Emil Chuang
  • TREATMENT OF GASTROPARESIS WITH TRIAZASPIRO[4.5]DECANONE
    Publication number: 20220288042
    Abstract: Provided herein is a method of treating or alleviating one or more symptoms of a disorder, disease, or condition mediated by a dopamine D2 or D3 receptor with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof. Also provided herein is a method of increasing the scrum prolactin level with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 1, 2022
    Publication date: September 15, 2022
    Inventor: Emil Chuang
  • TREATMENT OF GASTROPARESIS WITH TRIAZASPIRO[4.5]DECANONE
    Publication number: 20220071969
    Abstract: Provided herein is a method of treating or alleviating one or more symptoms of a disorder, disease, or condition mediated by a dopamine D2 or D3 receptor with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof. Also provided herein is a method of increasing the scrum prolactin level with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 15, 2021
    Publication date: March 10, 2022
    Inventor: Emil Chuang
  • Treatment of gastroparesis with triazaspiro[4.5]decanone
    Patent number: 11202776
    Abstract: Provided herein is a method of treating or alleviating one or more symptoms of a disorder, disease, or condition mediated by a dopamine D2 or D3 receptor with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof. Also provided herein is a method of increasing the serum prolactin level with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: December 21, 2021
    Inventor: Emil Chuang
  • TREATMENT OF GASTROPARESIS WITH TRIAZASPIRO[4.5]DECANONE
    Publication number: 20200155523
    Abstract: Provided herein is a method of treating or alleviating one or more symptoms of a disorder, disease, or condition mediated by a dopamine D2 or D3 receptor with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]de-can-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof. Also provided herein is a method of increasing the serum prolactin level with 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 11, 2018
    Publication date: May 21, 2020
    Inventor: Emil Chuang
  • Nutritional composition useful in the treatment of IBD patients
    Patent number: 10137108
    Abstract: Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: November 27, 2018
    Assignee: Nestec S.A.
    Inventors: Stephanie Blum-Sperisen, Magali Faure, Denis Breuille, Emil Chuang
  • NUTRITIONAL COMPOSITION USEFUL IN THE TREATMENT OF IBD PATIENTS
    Publication number: 20170368027
    Abstract: Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Inventors: Stephanie Blum-Sperisen, Magali Faure, Denis Breuille, Emil Chuang